This year is the year that the government policy strongly supports the pharmaceutical device, the domestic medical device market will surely usher in more opportunities. Shi Yonghui, head of investment and mergers and acquisitions in Greater China for Medtronic, a global orthopedic medical device giant, believes that the country's crackdown on illegal practices by foreign companies will have a big impact on the regulation of the entire medical sector.

China's medical device enterprises will not reproduce the high growth rate of 30% in previous years, but as the country encourages domestic medical devices to improve performance and upgrade, it will bring more opportunities for rapid development of China's medical device industry.

For example: China's cardiovascular and cerebrovascular medical equipment industry is facing four major development opportunities. First of all, in terms of biodegradable heart stents, there is a small gap between China's technical level and the international level, so China has the opportunity to participate in international competition and go global. In the next 3-5 years, the entry of Chinese companies will lead to a shake-up of the global market for biodegradable heart stents.

Secondly, in the market of pacemakers and other devices, the products of foreign enterprises are currently monopolized, and domestic devices only account for 12% of the market share. Under the background of China's encouragement to upgrade domestic medical devices and the government's increase in procurement, the replacement opportunities of domestic devices are greatly increased.

Third, in terms of 3D mapping equipment, although the market segment capacity is small, but the growth range is fast; Opportunities for preventive testing are great. "Given that the number of people with hypertension has reached 200 million in China, and the number of people with diabetes has reached 100 million, the trend of medical resources in China cannot be changed for a long time, so the opportunities for prevention and testing of products are also surging. Such as implantable monitoring devices, ECG monitoring technology and services are expected to receive more attention.

Domestic medical equipment enterprises merger or into the mainstream

Medtronic made frequent moves, successively acquired Aircraft and Lazarus Effect, two mechanical enterprises. And the case of merger and acquisition of foreign enterprises in this year is endless. So whether to adjust the strategy of domestic medical equipment enterprises?

From the development path of Medtronic and other medical device giants, it is mainly through restructuring and merger that they continue to grow bigger and stronger. China's medical device industry is now replicating the growth path of foreign giants.

According to relevant data shows: in the steady growth of demand and the extension of mergers and acquisitions, the pharmaceutical sector in the third quarter reported a high percentage of pre-increase, up to more than 70%. The agency is expected that medical devices, as a pharmaceutical segment industry, are expected to usher in accelerated development opportunities under the impetus of the new policies to promote the construction of health and elderly care services, graded diagnosis and treatment, and the localization of medical devices.